Short Communication Factors Influencing Time to CD4+ T Cell Counts >200 Cells/mm3 in HIV-Infected Individuals with CD4+ T Cell <50 Cells/mm3 at the Time of Starting Combination Antiretroviral Therapy

被引:0
|
作者
Ku, Nam Su
Song, Young Goo
Han, Sang Hoon
Kim, Sun Bean
Kim, Hye-won
Jeong, Su Jin
Kim, Chang Oh
Kim, June Myung
Choi, Jun Yong [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120752, South Korea
基金
新加坡国家研究基金会;
关键词
MEDICINE ASSOCIATION; DISEASES SOCIETY; VIRAL LOAD; VIRUS; DIAGNOSIS; AIDS; RECOMMENDATIONS; DETERMINANTS; TUBERCULOSIS; PROGRESSION;
D O I
10.1089/aid.2011.0282
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We evaluated factors influencing time to CD4(+) T cell counts >200 cells/mm(3) in HIV-infected individuals with CD4(+) T cell <50 cells/mm(3) starting combination antiretroviral therapy (cART). We included a total of 29 patients on successful cART for more than 1 year. In a logistic regression model, higher pre-cART CD4(+) T cell counts were significantly associated with shorter time to CD4(+) T cell counts >200cells/mm(3) in HIV-infected individuals with baseline CD4(+) T cell <50 cells/mm(3). In survival analysis, patients having higher pre-cART CD4(+) T cell counts, especially 40-49 cells/mm(3), were at significantly higher risk of achieving CD4(+) T cell counts >200 cells/mm(3).
引用
收藏
页码:1594 / 1597
页数:4
相关论文
共 50 条
  • [21] CD4 cell count at initiation of ART, long-term likelihood of achieving CD4 &gt;750 cells/mm3 and mortality risk
    Palella, F. J., Jr.
    Armon, C.
    Chmiel, J. S.
    Brooks, J. T.
    Hart, R.
    Lichtenstein, K.
    Novak, R. M.
    Yangco, B.
    Wood, K.
    Durham, M.
    Buchacz, K.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (09) : 2654 - 2662
  • [22] Mortality and its predictors among antiretroviral therapy naive HIV-infected individuals with CD4 cell count ≥350 cells/mm3 compared to the general population: data from a population-based prospective HIV cohort in Uganda
    Masiira, Ben
    Baisley, Kathy
    Mayanja, Billy N.
    Kazooba, Patrick
    Maher, Dermot
    Kaleebu, Pontiano
    GLOBAL HEALTH ACTION, 2014, 7 : 1 - 11
  • [23] Estimated average annual rate of change of CD4+ T-cell counts in patients on combination antiretroviral therapy
    Mocroft, Amanda
    Phillips, Andrew N.
    Ledergerber, Bruno
    Smith, Colette
    Bogner, Johannes R.
    Lacombe, Karine
    Wiercinska-Drapalos, Alicje
    Reiss, Peter
    Kirk, Ole
    Lundgren, Jens D.
    ANTIVIRAL THERAPY, 2010, 15 (04) : 563 - 570
  • [24] European mitochondrial haplogroups are associated with CD4+T cell recovery in HIV-infected patients on combination antiretroviral therapy
    Guzman-Fulgencio, Maria
    Berenguer, Juan
    Micheloud, Dariela
    Fernandez-Rodriguez, Amanda
    Garcia-Alvarez, Monica
    Angeles Jimenez-Sousa, Maria
    Maria Bellon, Jose
    Campos, Yolanda
    Cosin, Jaime
    Aldamiz-Echevarria, Teresa
    Catalan, Pilar
    Carlos Lopez, Juan
    Resino, Salvador
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (10) : 2349 - 2357
  • [25] Effects of Early and Delayed Antiretroviral Therapy on Plasma Anti-CD4 Autoreactive IgG and Its Association With CD4+ T-Cell Recovery in Acute HIV-Infected Individuals
    Song, Aixin
    Li, Zhen
    Luo, Zhenwu
    Lu, Xiaofan
    Wang, Rui
    Liu, Lifeng
    Xia, Wei
    Wan, Zhuang
    Zhang, Tong
    Su, Bin
    Jiang, Wei
    Wu, Hao
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [26] Frequency of Cytomegalovirus Viral Load in Iranian Human Immunodeficiency Virus-1-Infected Patients with CD4+Counts <100 Cells/mm3
    Jabbari, Mohammad Reza
    Soleimanjahi, Hoorieh
    Shatizadeh Malekshahi, Somayeh
    Gholami, Mohammad
    Sadeghi, Leila
    Mohraz, Minoo
    INTERVIROLOGY, 2021, 64 (03) : 135 - 139
  • [27] Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients
    Lempicki, RA
    Kovacs, JA
    Baseler, MW
    Adelsberger, JW
    Dewar, RL
    Natarajan, V
    Bosche, MC
    Metcalf, JA
    Stevens, RA
    Lambert, LA
    Alvord, WG
    Polis, MA
    Davey, RT
    Dimitrov, DS
    Lane, HC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (25) : 13778 - 13783
  • [28] As time goes by ... Would CD4+ T cells depletion induce early immunosenescence in HIV infected patients?
    Peres, Alessandra
    Lerias, Aline Grimaldi
    Kramer de Aguiar, Ana Karine
    Silva, Andrew Oliveira
    Costa, Caroline Borges
    Bemfica, Claudia
    de Vargas, Daiani Machado
    Andrade, Dieime de Souza
    Engelke, Douglas Senna
    Simoes Pires, Elisa Nicoloso
    Furtado, Gabriel Vasat
    Erpen, Gustavo Luiz
    De Nardin, Janaina
    Otton, Leticia Muner
    Tortorelli, Lucas Silva
    da Rosa, Priscila Machado
    Bogo Chies, Jose Artur
    MEDICAL HYPOTHESES, 2010, 74 (01) : 208 - 209
  • [29] Antiretroviral therapy in HIV-1-infected individualswithCD4 count below 100 cells/mm3 results in differential recovery of monocyte activation
    Patro, Sean C.
    Azzoni, Livio
    Joseph, Jocelin
    Fair, Matthew G.
    Sierra-Madero, Juan G.
    Rassool, Mohammed S.
    Sanne, Ian
    Montaner, Luis J.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2016, 100 (01) : 223 - 231
  • [30] Effect of Histone Deacetylase Inhibitors on HIV Production in Latently Infected, Resting CD4+ T Cells From Infected Individuals Receiving Effective Antiretroviral Therapy
    Blazkova, Jana
    Chun, Tae-Wook
    Belay, Bietel W.
    Murray, Danielle
    Justement, J. Shawn
    Funk, Emily K.
    Nelson, Amy
    Hallahan, Claire W.
    Moir, Susan
    Wender, Paul A.
    Fauci, Anthony S.
    JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (05) : 765 - 769